AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of ARS 348.25 trillion. The enterprise value is 419.37 trillion.

Market Cap	348.25T
Enterprise Value	419.37T

Important Dates

The next estimated earnings date is Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	Apr 15, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.17%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.77B

Valuation Ratios

The trailing PE ratio is 79.70.

PE Ratio	79.70
Forward PE	n/a
PS Ratio	6.00
PB Ratio	100.41
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.62, with an EV/FCF ratio of 22.81.

EV / Earnings	95.98
EV / Sales	6.54
EV / EBITDA	13.62
EV / EBIT	20.10
EV / FCF	22.81

Financial Position

The company has a current ratio of 0.66, with a Debt / Equity ratio of 20.22.

Current Ratio	0.66
Quick Ratio	0.43
Debt / Equity	20.22
Debt / EBITDA	2.51
Debt / FCF	3.81
Interest Coverage	6.53

Financial Efficiency

Return on equity (ROE) is 62.29% and return on invested capital (ROIC) is 16.13%.

Return on Equity (ROE)	62.29%
Return on Assets (ROA)	8.49%
Return on Invested Capital (ROIC)	16.13%
Return on Capital Employed (ROCE)	19.01%
Revenue Per Employee	1.06B
Profits Per Employee	79.44M
Employee Count	55,000
Asset Turnover	0.42
Inventory Turnover	4.03

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.74% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+15.74%
50-Day Moving Average	24,753.00
200-Day Moving Average	23,050.66
Relative Strength Index (RSI)	23.17
Average Volume (20 Days)	910

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.30

Income Statement

In the last 12 months, AbbVie had revenue of ARS 58.08 trillion and earned 4.37 trillion in profits. Earnings per share was 2,464.09.

Revenue	58.08T
Gross Profit	40.87T
Operating Income	18.90T
Pretax Income	3.83T
Net Income	4.37T
EBITDA	27.55T
EBIT	18.90T
Earnings Per Share (EPS)	2,464.09

Full Income Statement

Balance Sheet

The company has 5.73 trillion in cash and 70.13 trillion in debt, giving a net cash position of -64,400.38 billion.

Cash & Cash Equivalents	5.73T
Total Debt	70.13T
Net Cash	-64,400.38B
Net Cash Per Share	n/a
Equity (Book Value)	3.47T
Book Value Per Share	1,941.97
Working Capital	-13,575.18B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 19.39 trillion and capital expenditures -1,004.19 billion, giving a free cash flow of 18.38 trillion.

Operating Cash Flow	19.39T
Capital Expenditures	-1,004.19B
Free Cash Flow	18.38T
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.37%, with operating and profit margins of 32.54% and 7.59%.

Gross Margin	70.37%
Operating Margin	32.54%
Pretax Margin	6.60%
Profit Margin	7.59%
EBITDA Margin	47.43%
EBIT Margin	32.54%
FCF Margin	31.65%

Dividends & Yields

This stock pays an annual dividend of 488.77, which amounts to a dividend yield of 2.44%.

Dividend Per Share	488.77
Dividend Yield	2.44%
Dividend Growth (YoY)	102.60%
Years of Dividend Growth	4
Payout Ratio	257.71%
Buyback Yield	-0.06%
Shareholder Yield	2.38%
Earnings Yield	1.25%
FCF Yield	5.28%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.09. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.09
Piotroski F-Score	n/a